• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

Gilead crushes Abbvie at their own game!

Quote

Anonymous

Guest
An Update On Gilead's 2015 Outlook $GILD
http://www.seekingalpha.com/article/2922486

Nice article. States Gilead will receive many medical exceptions in ESI due to providers preferring its regimen. Also says Abbvie may see a 10% market share. Gilead also dominating in Europe.

Abbvie dealt a hand that was not as good as what Gilead had. Period! No amount of groveling is going to change that. Abbvie better stick to professionalism and asking for what we can win on and NOT annoying the crap out of providers and clinics to write for VPak when 9/10 times they prefer Harvoni and will write a medical exception to get what they want. No need for HSE's or AE's in this division....Gilead already providing wonderful programs for screening etc. a lot of overpaid people that cannot do much...and if they do ....they're only helping our competitor? Make changes Abbvie - starting from the top down. The fat lady is coming onto the stage to sing her final tune. Get ready!
 




Anonymous said:
An Update On Gilead's 2015 Outlook $GILD
http://www.seekingalpha.com/article/2922486

Nice article. States Gilead will receive many medical exceptions in ESI due to providers preferring its regimen. Also says Abbvie may see a 10% market share. Gilead also dominating in Europe.

Abbvie dealt a hand that was not as good as what Gilead had. Period! No amount of groveling is going to change that. Abbvie better stick to professionalism and asking for what we can win on and NOT annoying the crap out of providers and clinics to write for VPak when 9/10 times they prefer Harvoni and will write a medical exception to get what they want. No need for HSE's or AE's in this division....Gilead already providing wonderful programs for screening etc. a lot of overpaid people that cannot do much...and if they do ....they're only helping our competitor? Make changes Abbvie - starting from the top down. The fat lady is coming onto the stage to sing her final tune. Get ready!
Click to expand...

We are still in launch mode! We must exercise patience!!!
 




Anonymous said:
We are still in launch mode! We must exercise patience!!!
Click to expand...

Patience waiting for what??? More formulary losses?? Abbvie is getting scraps ...that's all. Very narrow net price margins based on our panic price slashing to get whatever is left.

We are expecting ESI scripts, but what we will actually get is 50-60% of that based on all the medical exceptions our providers will spend the time to do in order to use their preferred regimen - which need I say it...Harvoni. It is what it is not saying to not go out everyday and do your best work, but don't come across so desperate and pushy that you look pathetic and annoying to the point offices don't want you or your company coming in anymore. You know what I mean? It's thevreality of the situation and launch mode has NOTHING to do with it!
 




Anonymous said:
Patience waiting for what??? More formulary losses?? Abbvie is getting scraps ...that's all. Very narrow net price margins based on our panic price slashing to get whatever is left.

We are expecting ESI scripts, but what we will actually get is 50-60% of that based on all the medical exceptions our providers will spend the time to do in order to use their preferred regimen - which need I say it...Harvoni. It is what it is not saying to not go out everyday and do your best work, but don't come across so desperate and pushy that you look pathetic and annoying to the point offices don't want you or your company coming in anymore. You know what I mean? It's thevreality of the situation and launch mode has NOTHING to do with it!
Click to expand...

Patience for your pink slip. OMG, set me free.
 
















Top Bottom
Back
Quote